Summary of HIV resistance mutations obtained from ultra-deep sequencing (UDS) study.

aAnalyzed for HIV from VTC subjects only.1ART: K103N, E138A, Y181C, H221Y; PR: M46I, Q58E.1BRT: M41L, D67N, K70R, V75I, V90I, A98G, K101E, K101P, K103N, K103S, V106I, V106M, V108I, E138A, E138G, E138K, Q151M, V179D, Y181C, M184I, M184V, Y188L, G190A, L210W, T215Y, K219E, K219Q, H221Y, P225H, M230I; PR: V32I, M46I, M46L, I54M, Q58E, V82A, N83D, I84V, L90M.1CRT: K101E, K103N, V106I, E138A, E138G, E138K, Y181C; PR: D30N, M46I, M46L, Q58E, V82A.2ART: K103N, E138A, Y181C, H221Y; PR: M46I, Q58E.2BRT: M41L, D67N, K70R, V75I, K101E, K101P, K103N, K103S, V106M, V108I, E138A, E138K, E138G, Q151M, Y181C, M184I, M184V, Y188L, G190A, L210W, T215Y, K219E, K219Q, H221Y, P225H, M230I; PR: V32I, M46I, M46L, I54M, Q58E, V82A, N83D, I84V, L90M.2CRT: K101E, K103N, E138A, E138G, E138K, Y181C; PR: D30N, M46I, M46L, Q58E, V82A.3BRT: M41L, D67N, K70R, V75I, Q151M, M184I, M184V, L210W, T215Y, K219E, K219Q; PR: –.4ART: K103N, E138A, Y181C, H221Y; PR: –.4BRT: V90I, A98G, K101E, K101P, K103N, K103S, V106I, V106M, V108I, E138A, E138K, E138G, V179D, Y181C, Y188L, G190A, H221Y, P225H, M230I; PR: –.4CRT: K101E, K103N, V106I, E138A, E138K, E138G, Y181C; PR: –.5ART: K103N, E138A, Y181C, H221Y; PR: –.5BRT: K101E, K101P, K103N, K103S, V106M, V108I, E138A, E138G, E138K, Y181C, Y188L, G190A, H221Y, P225H, M230I; PR: –.5CRT: K101E, K103N, E138A, E138G, E138K, Y181C; PR: –.6ART: K103N, E138A, Y181C, H221Y; PR: M46I, Q58E.6BRT: –; PR: V32I, M46I, M46L, I54M, Q58E, V82A, N83D, I84V, L90M.6CRT: –; PR: D30N, M46I, M46L, Q58E, V82A.Fisher’s Exact test was used to determine if there was a significant difference in the occurrence of resistance mutations between clustered and non-clustered subjects. Significant findings (p